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patient exposed to asbestos for more than 50
yearsTo the Editor,
In their article “Malignant mesothelioma of the tunica
vaginalis testis”, Chen et al. [1] reported the first case of
malignant mesothelioma of the tunica vaginalis testis in
Taiwan. It is a rare but lethal malignancy. We report a
second case in a patient in Taiwan with a history of asbestos
exposure, but with a good prognosis. This research project
has been approved by Chang Gung Memorial Hospital
Institutional Review Board, No. 102-0311B. Oral informed
consent and accompanying images were obtained from the
patient for the publication of this article.
A 76-year-old fisherman was admitted because of the
progressive enlargement of a painless right scrotal mass,
which had been present for 2 years. He lived in a house that
had been constructed with asbestos material 50 years
previously. Scrotal ultrasonography revealed a diffusely
heterogeneous echogenic hydrocele and a well-
circumscribed ovoid mass in the lining of the hydrocele
(Fig. 1A). The patient underwent scrotal exploration. Under
the impression of malignancy, a radical orchiectomy was
performed. The pathology indicated a biphasic malignant
mesothelioma of the testis, epididymis, and tunica vagi-
nalis (Fig. 1B), which were characterized by diffused ex-
pressions of calretinin and Wilms tumor-1 protein (WT1).
Computer tomography revealed no lymph node or other
organ involvement. The patient has been well for more
than 8 months of follow-up.
Mesothelioma arises from the serosa of the pleura,
peritoneum, pericardium, and tunica vaginalis [2].Conflicts of interest: None of the authors have any conflicts of
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1607-551X/Copyright ª 2014, Kaohsiung Medical University. Published bParatesticular malignant mesotheliomas (PMMs) make up
approximately 0.3e1.4% of all malignant mesotheliomas
[2]. The incidence of PMM peaks in the 6the8th decades of
life. Only approximately 35e40% of the patients have a
history of asbestos exposure [3]. However, PMM may also be
related to trauma, prolonged existence of a hydrocele,
radiation, and genetic factors. Since 2002, there have been
less than 70 cases of PMM worldwide.
The usual presentations are a painless scrotal mass with
a firm texture and hydrocele. Even under accurate physical
examination, a definitive diagnosis is often delayed
because of misinterpretation of repeated hydrocele, re-
fractory epididymo-orchitis, or scrotal or inguinal hernia
[3]. Therefore, to assist clinicians in making a differential
diagnosis, preoperative image studies such as scrotal ul-
trasonography, pelvis computed tomography (CT), mag-
netic resonance imaging (MRI), and positron emission
tomography (PET) are important [4]. Scrotal ultrasonogra-
phy is the main tool, which often reveals a thickened tunica
vaginalis wall, a solid cystic tumor involving the testis and
epididymis, and heterogeneous echo texture within hydro-
celes [4]. Pelvic nodes are often detected at advanced
stages, but para-aortic lymph nodes are primarily involved.
Therefore, CT study detects approximately 15% cases of
retroperitoneal lymph node metastasis [4].
There are no definite therapeutic principles, although
radical orchiectomy with an inguinal-scrotal approach is
the mainstay of first-line surgical treatment [3]. Para-
testicular malignant mesotheliomas are aggressive malig-
nancies, which may supervene as hematogenous or
lymphatic metastases. Sixty percent of patients have a
recurrence within 2 years and 30% of patients have a mor-
tality after 2 years [2,3]. Cisplatin-based chemotherapy and
radiotherapy have limited efficacy [5]. Age is the most
important prognostic factor for survival, and a diagnostic
age younger than 60 years provides better outcomes [3,5].y Elsevier Taiwan LLC. All rights reserved.
Figure 1. (A) Scrotal ultrasonography reveals a diffusely heterogeneous echogenic hydrocele and a well-circumscribed ovoid
mass (arrow) in the lining of the hydrocele. (B) Multiple tumors are present over the testis, epididymis, and tunica vaginalis.
538 Letter to the EditorDecades ago, asbestos was widely used in Taiwan
because of the development of foundries, factories, and
massive setting up of public buildings. Therefore, public
health programs for adult males should have a genital ex-
amination, followed by further image surveillance if
abnormal clinical findings are found, especially in elderly
males.
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